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Environmental tobacco smoke (ETS; i.e.,
passive or second-hand smoke) is a pervasive
contaminant in public places. ETS is a mix-
ture of sidestream and mainstream cigarette
smoke (SSCS and MSCS, respectively).
SSCS constitutes 85% of ETS. Cigarette
smoke is one of the greatest exogenous
sources of free radicals (1). More than 4,000
compounds have been identiﬁed in cigarette
smoke (2), many of which are capable of
generating reactive oxygen species (ROS)
during metabolism. Major sources of ROS
are from both gas and tar phases of cigarette
smoke. In the tar phase, at least four differ-
ent free radical species can be identified.
Among them, semiquinone can reduce oxy-
gen to form superoxide (O2·–) in the pres-
ence of water. Nitric oxide (NO) exists in
cigarette smoke up to 500 ppm, which prob-
ably represents one of the greatest exogenous
sources of NO to which humans are
exposed. The NO reacts quickly with O2 to
form peroxynitrite (ONOO–) and gives rise
to alkyl peroxynitrite (ROONO) if it reacts
with organic peroxyl radical (3,4). 
ROS such as NO, ONOO–, and
ROONO have been recognized as important
mediators of damage in biological systems
(5). Furthermore, cigarette smoke can also
induce endogenous production of ROS such
as superoxide anions, hydrogen peroxide, and
hydroxyl radicals, which may increase intra-
cellular oxidative stress. Oxidative stress was
indicated by an alteration of antioxidant
enzymes in heart, liver, and lung tissues (6,7).
Exposure to ETS at work increased the level
of certain antioxidant enzymes in the blood
of employees (8). Oxidative damage to cellu-
lar components occurs when the production
of ROS overwhelms the cell’s antioxidant
defenses and leads to lipid peroxidation and
decreased tissue antioxidant levels. ROS also
can initiate a series of cellular responses that
play an important role in the proinﬂamma-
tory process. Our previous study indicated
that a small amount of SSCS (30 min/day, 5
days/week for 10 days) in immunodeﬁcient
mice caused lung injury and lipid peroxida-
tion in the lung and liver (9). To investigate
whether moderate intake of SSCS initiates
proinflammatory response and promotes
oxidative damage in healthy, old mice, we
tested hepatic lipid peroxide and vitamin E
level and splenocyte interleukin-6 (IL-6) pro-
duction in both nonsmoking and smoking
mice. Our hypothesis is that multiple antiox-
idants may help to prevent oxidation and
proinﬂamatory response induced by SSCS.
Materials and Methods
Experimental design. We purchased 13-
month-old C57BL/6 female mice from
Charles River Laboratories (Wilmington,
DE). They were housed in transparent plastic
cages with stainless wire lids (four mice per
cage) in the animal facility of the Arizona
Health Science Center. The housing facility
was maintained at 20–22°C and 60–80% rel-
ative humidity, with a 12-hr light–dark cycle.
The mice had free access to water and a semi-
puriﬁed diet (4% mouse diet, #7001; Teklad,
Madison, WI). After 2 weeks of housing, the
mice were randomly divided into four groups
with 12 mice in each group: group I, non-
smoking group fed control diet; group II,
nonsmoking group fed multiple antioxidants
diet; group III, 30-min SSCS exposure fed
control diet; group IV, and 30-min SSCS
exposure fed multiple antioxidants diet. The
control diet was AIN 93 M, synthetic pelleted
diet (Dyets Inc., Bethelehem, PA). It was sup-
plemented with placebo beadlets. The supple-
mented diet was AIN 93 M synthetic,
supplemented with β-carotene (15 mg/g diet;
Hoffmann-la Roche, Nutley, NJ), biofla-
vanoids (300 µg/g diet), coenzyme Q10 (300
µg/g diet), D-α-tocopherol (10-fold increase
over control diet, 1.5 mg/g diet), L-ascorbic
acid (300 µg/g diet), L-carnitine (300 µg/g
diet), magnesium (5-fold increase over control
diet, 4.2 mg/g diet), N-acetylcysteine (300
µg/g diet), retinol (80 µg/g diet), selenium
(1.8 µg/g diet), and zinc (289 µg/g diet; 3-
fold increase over control diet).
Sidestream cigarette exposures. Standard
research cigarettes (1R4; University of
Kentucky Smoking & Health Effects
Laboratory, Lexington, KY) were used in this
study. The mice were exposed to SSCS for
30 min/day, two cigarettes every 10 min, 5
days/week using an IN-TOX vacuum-drawn
(15 L/min) exposure system (Albuquerque,
NM) modiﬁed for cigarette smoke exposure.
The methodology for SSCS exposure and
aerosol characterization has been previously
reported (9). The SSCS-exposure mice were
placed in the IN-TOX exposure system for a
30-min exposure period. SSCS was generated
in the following pattern: the ﬁrst two lit ciga-
rettes were placed upright in a clamp 2.5 cm
below the bottom edge of an inverted 220-
cm3 funnel and allowed to burn for 10 min.
The second two cigarettes were lit at the 10-
min time point of the exposure period and
replaced the first two cigarettes. Then the
second two were replaced by the third until
30-min exposure was completed. The con-
trol group was treated in a similar manner
except that the cigarettes were not lit. The
SSCS treatment lasted for 2 months. The
animals were killed the day after the last
exposure. Spleen and liver tissues were then
removed for cytokine, lipid peroxidation,
and vitamin E assays. 
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2001.Lipid peroxidation assay. Quantitative
determination of lipid peroxides in liver was
done by using a quick LPO-CC K-ASSAY
(Hamiya Biomedical Company, Seattle,
WA). The range of the method is approxi-
mately 2–300 nmol/mL. Briefly, 0.2 mg
mouse liver was homogenized in 1 mL chlo-
roform (CHCl3)/methanol (2:1 v/v). Next,
0.3 mL 0.9% NaCl was added to clarify, and
the mixture was centrifuged at 3,000 × g for
10 min. The supernatant was collected and
evaporated under nitrogen gas. We then
added 100 µL of isopropanol to dissolve the
lipid residue. Test sample, standard, and
control were added 20 µL in triplicate in 96-
well microplate. Lipid peroxides were quan-
titated by colorimetrically measuring
methylene blue at 675 nm. Lipid peroxide
values were calculated following the manu-
facturer’s instructions.
Vitamin E determination. We measured
vitamin E by HPLC as described previously
(9). Briefly, about 0.2 g liver tissue was
homogenized in 1.0 mL water. Butylated
hydroxytoluene was added to prevent oxida-
tion of α-tocopherol from the homogenate.
Extracts were evaporated under a steady ﬂow
of nitrogen gas at 20°C and then redissolved
in 0.5 mL of methanol injection onto a C18
column (3.9 × 150 mm NovaPak; Millipore,
Bedford, MA). The mobile phase was com-
posed of methanol: distilled water in the ratio
of 98:2 (by volume) with a ﬂow rate of 1.2
mL/min. α-Tocopherol, eluting at 6.5 min,
was monitored by a ﬂuorescence detector at
290 nm excitation and 340 nm emission
wavelengths. A set of α-tocopherol standard
concentrations was analyzed to make a stan-
dard curve and to verify calibration. 
Cytokine ELISA assay. Mitogen-stimu-
lated splenocytes were cultured in triplicate
in 96-well microtiter plates as described
previously (10). Brieﬂy, the spleen was gen-
tly teased with forceps in a culture medium
(RPMI 1640 containing 10% fetal bovine
serum, 2 nmol/L glutamine, 1 × 105 U/L
penicillin and streptomycin), producing
suspension of spleen cells. Red blood cells
were lysed by the addition of a lysis buffer
(0.16 mol/L ammonia chloride Tris buffer,
pH 7.2) at 37°C for 3 min. The cells were
then washed twice with culture medium. Cell
concentration was adjusted to 1 × 107
cells/mL (splenocyte viability was determined
by trypan blue exclusion). Splenocytes were
cultured in triplicate on 96-well, ﬂat-bottom
culture plates (Falcon 3072; Becton
Dickinson, Lincoln Park, NJ) with culture
medium. Splenocytes were incubated 24 hr
after the addition of lipopolysaccharide 1 ×
10–2 g/L (Gibco, Grand Island, NY) to
induce IL-6 production in a 37°C, 5% car-
bon dioxide incubator. After 24 hr of incuba-
tion, supernatants were collected and stored
at –70°C until analysis. To measure the
quantity of murine IL-6 in supernatants of
splenocyte cultures, we used a speciﬁc solid-
phase ELISA assay, using the multiple anti-
body sandwich principle. An IL-6 kit was
obtained from Pharmingen (Endogen, MA).
All tests were performed according to the
manufacturer’s instructions and were done in
triplicate in 96-well microtiter plates.
Statistical analyses. Statistical analyses
were carried out using an SPSS 10.0
Windows statistical package (SPSS Inc.,
Chicago, IL). Values are expressed as the
mean ± SD. Values were compared using a
one-way analysis of variance (ANOVA), fol-
lowed by a two-tailed Student’s t-test for
comparison between any two groups. Values
with p < 0.05 were considered signiﬁcant.
Results
Figure 1 shows the lipid peroxide produc-
tion in mouse liver. The liver is the major
organ that has been studied for tissue lipid
peroxidation. The production of hepatic
lipid peroxides was signiﬁcantly increased by
SSCS exposure (p < 0.05). However, the
production of hepatic lipid peroxides was
signiﬁcantly decreased in both nonsmoking
and smoking mice with antioxidant supple-
mentation (p < 0.05). 
Hepatic vitamin E levels in each group
are shown in Figure 2. Hepatic vitamin E in
smoke-exposed mice was significantly
decreased compared to mice not exposed to
smoke (p < 0.05). Hepatic vitamin E in both
exposed and control groups fed multiple
antioxidants was significantly higher than
in smoke-exposed mice fed a control diet
(p < 0.05).
We determined the production of IL-6
in splenocytes in each group (Figure 3).
Overproduction of IL-6 in the spleen was
shown in smoke-exposed mice compared to
control mice (p < 0.05). IL-6 production in
spleen was significantly reduced in smoke-
exposed mice with antioxidant supplementa-
tion compared to exposed mice on the
control diet (p < 0.05). 
Discussion
Cigarette smoke contains large amounts of
both carbon- and oxygen-centered free radi-
cals, which can directly or indirectly initiate
and propagate the process of lipid peroxida-
tion. The results of the present study suggest
that SSCS-induced lipid peroxidation was
increased in the liver. A cell may defend
itself against oxidative stress through the use
of antioxidants. These antioxidants are con-
sumed in the process of scavenging free radi-
cals before more important structures are
damaged. Antioxidants can be conveniently
divided into water soluble and lipid soluble,
and exist in environments such as lipopro-
teins and cell membranes to prevent the
propagation phase of lipid peroxidation
(chain-breaking antioxidants). Of the aque-
ous molecules, the best known is vitamin C
(ascorbate), which is the most powerful elec-
tron donor and the ﬁrst plasma antioxidant
to be sacrificed upon exposure to oxidative
stress (11). There is evidence that ascorbate
contributes up to 24% of the total peroxyl
radical-trapping antioxidant capacity in the
human plasma (12–14). Evidence exists that
ascorbic acid inhibits both phagocyte-
induced and endothelial cell-induced and
lipid peroxidation processes (15). Vitamin E
is a lipid-soluble, powerful chain-breaking
antioxidant (16). It has a protective role
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Figure 1. Hepatic lipid peroxide production.
*Compared to nonsmoking control (p < 0.05). #Compared
to control diet (p < 0.05).
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Figure 2. Hepatic vitamin E level.
*Compared to nonsmoking control (p < 0.05). #Compared
to control diet (p < 0.05).
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Figure 3. Splenocyte IL-6 production in mouse
splenocytes.
*Compared to nonsmoking control (p < 0.05). #Compared
to control diet (p < 0.05).
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Antioxidantsagainst the damaging effects of smoke,
including in the immune cells that produced
large amounts of oxidants (17–19). Our data
indicated that the tissue antioxidant (e.g.,
vitamin E in SSCS-exposed mouse liver) was
depleted. Tissue vitamin C level was not
determined in this experiment. It has been
reported that plasma levels of ascorbic acid,
the reduced form of vitamin C, were signiﬁ-
cantly lower in active smokers (20). These
results suggest that the cell antioxidant
defense system is affected by SSCS exposure.
Proinﬂammatory cytokine IL-6 is closely
linked with pathology in a wide range of dis-
eases and conditions that have an inﬂamma-
tory basis. Our data suggest that SSCS
stimulated IL-6 production in the spleen,
while antioxidant vitamins reduced it.
Oxidants stimulate proinflammatory
cytokine production though activation of
nuclear factor κB (NF-kB). Antioxidant
nutrients have the potential to modulate
inflammatory aspects of immune function
by disrupting the NFkB pathway (21).
Another study shows that nicotine stimulates
the release of norepinephrine, which can
induce IL-6 synthesis in the liver and spleen
(22). There is also evidence that tobacco gly-
coprotein stimulates the immune system and
induces IL-6 mRNA synthesis in spleen cells
(23). Serum levels of nicotine and tobacco
glycoprotein were not determined in the pre-
sent study, so we cannot exclude the possi-
bility that nicotine or tobacco glycoprotein
induced IL-6 production in the spleen.
Overall, we observed that moderate lev-
els of SSCS exposure induced oxidation and
promoted inflammatory cytokine produc-
tion. Multiple antioxidant supplementations
could attenuate lipid peroxidation and
proinflammatory response. Nevertheless,
further studies need to be conducted to
explore the most plausible pathway of
inﬂammatory immune response upon expo-
sure to SSCS. The antioxidant enzyme activ-
ities and other antioxidant levels of tissue or
serum should be tested as well. 
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